A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing ...

A dual-target CAR T cell therapy approach shows promise for slowing tumor growth in a notoriously aggressive and fast-growing ...

A Gilead Sciences-backed therapy made with a patient's own white blood cells shrank tumors in 62% of patients with recurrent ...

Cancer patients given experimental treatment that programmes the body to attack rogue cells live 40 per cent longer, major research shows.

Brady Cullen's baseball teammates from North Reading High lined the hall of Mass General, holding signs and cheering him on.

By Brandon Truitt Click here for updates on this story Massachusetts (WBZ) — The baseball field at North Reading High School has been getting a lot of use this season. They’ve made it to the playoffs ...

Karla Flores was diagnosed with a rare brain tumor. A misplaced MRI found a second, nearly inoperable, tumor on her spine.

Manmeet Ahluwalia, MD, MBA, FASCO, chief of medical oncology, chief scientific officer, and deputy director of the Miami ...

Former President Biden made his first public remarks since his cancer diagnosis at a Memorial Day event in Delaware ...

Today some of the most aggressive solid tumor cancers remain stubbornly resistant to treatment. There are many reasons why ...

Patritumab deruxtecan demonstrated activity against brain metastases and leptomeningeal disease in a phase 2 trial of patients with advanced cancers.